Articles

The stock market is giving Big Tech tougher demands for its continued support.

Eli Lilly’s stock heads for biggest selloff since 2008 after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.

Agency to auction $125 billion next week, unchanged from last quarter

One analyst says that AMD’s muted guidance is unlike what Wall Street has come to expect of “AI names.”

U.S. businesses 233,000 new jobs in October to mark the biggest gain in 14 months, paycheck company ADP said, suggesting the labor market is somewhat stronger than previously believed.

The U.K.’s chancellor of the exchequer confirmed the government will lift the U.K.’s national minimum wage by 6.7% in April 2025 to hourly rates of £12.21 ($15.84)

Caterpillar’s stock drops after a rare profit miss, while revenue was below expectations for a fourth straight quarter.

Oil futures rose early Wednesday, attempting to find their footing after ending the previous session at seven-week lows as investors continued to fade geopolitical worries and turned their attention to a shaky demand outlook and prospects for ample supply.

“We continue to see momentum with ongoing product launches and we are increasingly excited about the potential of our pipeline,” the company’s CEO said.

Stocks are now expected to weaken versus bonds, argue UBS strategists.

Amazon’s stock has trailed the S&P 500 over three months, owing in part to concerns about operating income and margin compression. Will Thursday’s earnings alleviate fears?

The U.S. stock market is about to enter historically its best six months of the year, after defying the popular Wall Street adage to “sell in May and go away” with strong gains.